期刊文献+

“鸡尾酒”式免疫干预法防治1型糖尿病的最新研究进展

原文传递
导出
摘要 1型糖尿病(T1DM)是一种自身免疫性疾病,以遗传为基础.在某些环境因素作用下.诱发机体免疫系统功能障碍导致胰岛β细胞自身免疫性损伤,使其丧失合成和分泌胰岛素能力,引起糖代谢调节絮乱的自身免疫性疾病;
出处 《内科理论与实践》 2013年第3期221-224,共4页 Journal of Internal Medicine Concepts & Practice
  • 相关文献

参考文献24

  • 1Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes [J]. Nature, 2010, 464(7293): 1293-1300.
  • 2Maahs DM, Rewers M. Editorial: mortality and renal disease in type 1 diabetes mellitus--progress made, more to be done [J]. J Clin Endocrinol Metab, 2006,91 (10): 3757-3759.
  • 3The Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on residual βcellfunction in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial [J]. Ann Intern Med, 1998, 128(7): 517-523.
  • 4Bresson D, yon Herrath M. Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside [J]. Diabetes Care, 2009, 32(10): 1753-1768.
  • 5Michels AW, Eisenbarth GS. Immune intervention in type 1 diabetes [J]. Semin Immunol, 2011, 23(3): 214- 219.
  • 6Penaranda C, Tang Q, Bluestone JA. Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells [J]. J Immunol, 2011, 187(4): 2015-2022.
  • 7Bach JF. Anti-CD3 antibodies for type 1 diabetes: beyond expectations [J]. Lancet, 2011, 378(9790): 459- 460.
  • 8Sprangers B, Van der Schueren B, GiUard P, et al. Otelixizumab in the treatment of type 1 diabetes mellitus [J]. Immunotherapy, 2011, 3(11): 1303-1316.
  • 9Herold KC, Gitelman S, Greenbaum C, et al. Treatment of patients with new onset type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 years [J]. Clin Immunol, 2009, 132(2): 166-173.
  • 10Bresson D, Togher L, Rodrigo E, et al. Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs [J]. J Clin Invest, 2006, 116(5): 1371-1381.

二级参考文献20

  • 1Bottini N.Role of PTPN22 in type 1 diabetes and other autoimmune diseases,Seminars in Immunology.2006,18:207-213.
  • 2Knip M,Veijola R,Virtanen SM,et al.Environmental triggers and determinants of type Ⅰ diabetes.Diabetes,2005,54 (Suppl 2):S125-S136.
  • 3Burt RK,Arnold R,Emmons R,et al.Stem cell therapy for autoimmune disease:overview of concepts from the snowbird 2002 tolerance and tissue regeneration meeting.Bone Marrow Transplantat,2003,32:3-5.
  • 4Beard ME,Willis JA,Scott RS,et al.Is type 1 diabetes transmissible by bone marrow allograft? Diabetes Care.2002,25:799-800.
  • 5Voltarelli JC,Couri CE,Stracieri AB,et al.Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.JAMA,2007,297:1568-1576.
  • 6Skyler JS.Cellular therapy for type 1 diabetes:has the time come?JAMA,2007,297:1599-1600.
  • 7Tyndall A,Fassas A,Passweg J,et al.Autologous haematopoietic stem cell transplants for autoimmune disease-feasibility and transplantrelated mortality.Autoimmune disease and lymphoma working parties of theEuropean group for blood and marrow transplantation,the european league against rheumatism and the international stem cell project for autoimmune disease.Bone Marrow Transplant,1999,24:729-734.
  • 8Openshaw H,Nash RA,McSweeney PA.High-dose immunosuppression and hematopoietic stem cell transplantation in autoimmune disease:clinical review.Biol Blood Marrow Transplant,2002,8:233 -248.
  • 9Tyndall A,Passweg J,Gratwohl A.Haemopoietic stem cell transplantation in the treatment of severe autoimmune diseases 2000.Ann Rheum Dis,2001,60:702-707.
  • 10Couri CEB,Oliveira MCB,Stracieri ABPL,et al.C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.JAMA,2009,301:1573-1579.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部